Have a feature idea you'd love to see implemented?
Let us know!
BNGO Bionano Genomics Inc
Price (delayed)
$0.4205
Market cap
$36.16M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.02
Enterprise value
$42.3M
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for
Highlights
Bionano Genomics's gross profit has increased by 33% YoY and by 2.7% from the previous quarter
BNGO's gross margin is up by 14% year-on-year and by 5% since the previous quarter
Bionano Genomics's debt has soared by 159% YoY but it has decreased by 27% from the previous quarter
The company's net income fell by 39% YoY but it rose by 10% QoQ
BNGO's equity has plunged by 63% YoY and by 2.9% from the previous quarter
BNGO's quick ratio has dropped by 62% year-on-year and by 8% since the previous quarter
Key stats
What are the main financial stats of BNGO
Market
Valuations
Earnings
Shares outstanding
86M
Market cap
$36.16M
Enterprise value
$42.3M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.35
Price to sales (P/S)
0.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.16
Revenue
$36.58M
EBIT
-$199M
EBITDA
-$185.43M
Free cash flow
-$106.1M
Per share
Balance sheet
Liquidity
EPS
-$5.02
Free cash flow per share
-$1.57
Book value per share
$1.2
Revenue per share
$0.54
TBVPS
$1.47
Total assets
$129.36M
Total liabilities
$49.03M
Debt
$27.57M
Equity
$80.34M
Working capital
$23.39M
Debt to equity
0.34
Current ratio
1.63
Quick ratio
0.97
Net debt/EBITDA
-0.03
Margins
Efficiency
Dividend
EBITDA margin
-506.9%
Gross margin
29%
Net margin
-558%
Operating margin
-499.9%
Return on assets
-119.4%
Return on equity
-215.8%
Return on invested capital
-209.1%
Return on capital employed
-215.9%
Return on sales
-544%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BNGO stock price
How has the Bionano Genomics stock price performed over time
Intraday
-0.07%
1 week
-2.59%
1 month
-5.51%
1 year
-84.93%
YTD
-77.75%
QTD
-7.36%
Financial performance
How have Bionano Genomics's revenue and profit performed over time
Revenue
$36.58M
Gross profit
$10.6M
Operating income
-$182.86M
Net income
-$204.1M
Gross margin
29%
Net margin
-558%
The company's net income fell by 39% YoY but it rose by 10% QoQ
Bionano Genomics's gross profit has increased by 33% YoY and by 2.7% from the previous quarter
BNGO's operating income is down by 24% YoY but it is up by 11% from the previous quarter
Bionano Genomics's net margin has decreased by 20% YoY but it has increased by 8% from the previous quarter
Growth
What is Bionano Genomics's growth rate over time
Valuation
What is Bionano Genomics stock price valuation
P/E
N/A
P/B
0.35
P/S
0.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.16
The EPS has increased by 17% QoQ but it has decreased by 3.1% YoY
BNGO's price to book (P/B) is 91% lower than its 5-year quarterly average of 3.8 and 50% lower than its last 4 quarters average of 0.7
BNGO's equity has plunged by 63% YoY and by 2.9% from the previous quarter
The P/S is 98% below the 5-year quarterly average of 35.5 and 59% below the last 4 quarters average of 1.9
Bionano Genomics's revenue has increased by 16% YoY but it has decreased by 2.4% QoQ
Efficiency
How efficient is Bionano Genomics business performance
Bionano Genomics's return on assets has shrunk by 143% YoY and by 9% QoQ
Bionano Genomics's ROIC has plunged by 123% YoY
Bionano Genomics's return on equity has decreased by 22% QoQ
The ROS has decreased by 19% YoY but it has increased by 8% QoQ
Dividends
What is BNGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BNGO.
Financial health
How did Bionano Genomics financials performed over time
BNGO's total assets is 164% greater than its total liabilities
BNGO's quick ratio has dropped by 62% year-on-year and by 8% since the previous quarter
BNGO's current ratio has dropped by 55% year-on-year but it is up by 12% since the previous quarter
Bionano Genomics's debt is 66% less than its equity
Bionano Genomics's debt has soared by 159% YoY but it has decreased by 27% from the previous quarter
BNGO's equity has plunged by 63% YoY and by 2.9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.